Nuvectis Pharma
Price & Volume
Stats
See moreOpen | $8.18 |
Previous Close | $8.31 |
Day Range | $8.13-$8.39 |
52W Range | $5.34-$11.52 |
Market Cap | $210M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.37 |
News
See moreYahoo Finance • 28 days ago
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
Yahoo Finance • 2 months ago
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Yahoo Finance • 3 months ago
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
Yahoo Finance • 4 months ago
Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors
About
CEO | Mr. Ron Bentsur M.B.A. |
Address | 1 Bridge Plaza, Fort Lee, NJ, United States, 07024 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
